More men named Michael are presenting at JP Morgan healthcare conference than women

A STAT analysis pointed out a lack of gender diversity among company presentations at this week’s J.P. Morgan Healthcare Conference. Twenty female CEOs will be presenting corporate updates at the event in San Francisco—fewer than the 22 male presenters named Michael.

In all, men represent 94 percent of the 540 corporate update presenters at the conference. They also represent 77 percent of the speakers for the event’s special sessions, including four of the nine panel discussions featuring no women panelists or moderators.

“As companies get larger and larger, fewer and fewer of the CEOs are women,” said Lisa Suennen, managing director at GE Ventures. “I don’t expect it to change a lot in my lifetime.”

The conference’s organizers aren’t to blame for the lack of diversity, STAT wrote. Instead, the blame would fall on the companies themselves, most of which are mature biopharmaceutical companies with too few women in the C-suite, according to Nina Kjellson, a general partner at the venture capital firm Canaan.

Ancillary conferences surrounding the main J.P. Morgan event have a greater female presence but still skew male overall, like the Biotech Showcase, which has a 67 percent/33 percent split among male and female speakers, and no all-male panels.

“Our attendees don’t want a program that’s like an echo chamber,” said conference organizer Anna Chrisman. “When we include people with different backgrounds, it creates a more meaningful and engaging event.”

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”